» Articles » PMID: 34987369

Theta Oscillations at Subthalamic Region Predicts Hypomania State After Deep Brain Stimulation in Parkinson's Disease

Overview
Specialty Neurology
Date 2022 Jan 6
PMID 34987369
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Subthalamic nucleus (STN) deep brain stimulation (DBS) is an effective treatment for the motor impairments of patients with advanced Parkinson's disease. However, mood or behavioral changes, such as mania, hypomania, and impulsive disorders, can occur postoperatively. It has been suggested that these symptoms are associated with the stimulation of the limbic subregion of the STN. Electrophysiological studies demonstrate that the low-frequency activities in ventral STN are modulated during emotional processing. In this study, we report 22 patients with Parkinson's disease who underwent STN DBS for treatment of motor impairment and presented stimulation-induced mood elevation during initial postoperative programming. The contact at which a euphoric state was elicited by stimulation was termed as the hypomania-inducing contact (HIC) and was further correlated with intraoperative local field potential recorded during the descending of DBS electrodes. The power of four frequency bands, namely, θ (4-7 Hz), α (7-10 Hz), β (13-35 Hz), and γ (40-60 Hz), were determined by a non-linear variation of the spectrogram using the concentration of frequency of time (conceFT). The depth of maximum θ power is located approximately 2 mm below HIC on average and has significant correlation with the location of contacts ( = 0.676, < 0.001), even after partializing the effect of α and β, respectively ( = 0.474, = 0.022; = 0.461, = 0.027). The occurrence of HIC was not associated with patient-specific characteristics such as age, gender, disease duration, motor or non-motor symptoms before the operation, or improvement after stimulation. Taken together, these data suggest that the location of maximum θ power is associated with the stimulation-induced hypomania and the prediction of θ power is frequency specific. Our results provide further information to refine targeting intraoperatively and select stimulation contacts in programming.

Citing Articles

Current and future applications of local field potential-guided programming for Parkinson's disease with the Percept™ rechargeable neurostimulator.

Saengphatrachai W, Jimenez-Shahed J Neurodegener Dis Manag. 2024; 14(5):131-147.

PMID: 39344591 PMC: 11524207. DOI: 10.1080/17582024.2024.2404386.


Subthalamic high-beta oscillation informs the outcome of deep brain stimulation in patients with Parkinson's disease.

Chen P, Chen Y, Tu P, Liu T, Chen M, Wu H Front Hum Neurosci. 2022; 16:958521.

PMID: 36158623 PMC: 9493001. DOI: 10.3389/fnhum.2022.958521.

References
1.
Cavanagh J, Wiecki T, Cohen M, Figueroa C, Samanta J, Sherman S . Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nat Neurosci. 2011; 14(11):1462-7. PMC: 3394226. DOI: 10.1038/nn.2925. View

2.
Zavala B, Tan H, Ashkan K, Foltynie T, Limousin P, Zrinzo L . Human subthalamic nucleus-medial frontal cortex theta phase coherence is involved in conflict and error related cortical monitoring. Neuroimage. 2016; 137:178-187. PMC: 4927260. DOI: 10.1016/j.neuroimage.2016.05.031. View

3.
Seijo F, Alvarez de Eulate Beramendi S, Santamarta Liebana E, Lozano Aragoneses B, Saiz Ayala A, Fernandez de Leon R . Surgical adverse events of deep brain stimulation in the subthalamic nucleus of patients with Parkinson's disease. The learning curve and the pitfalls. Acta Neurochir (Wien). 2014; 156(8):1505-12. DOI: 10.1007/s00701-014-2082-0. View

4.
Rodriguez-Oroz M, Lopez-Azcarate J, Garcia-Garcia D, Alegre M, Toledo J, Valencia M . Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Brain. 2010; 134(Pt 1):36-49. DOI: 10.1093/brain/awq301. View

5.
Krack P, Kumar R, Ardouin C, Dowsey P, McVicker J, Benabid A . Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord. 2001; 16(5):867-75. DOI: 10.1002/mds.1174. View